Insider Transactions in Q2 2025 at Nuvation Bio Inc. (NUVB)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Stacy Markel CHIEF PEOPLE OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+25.26%
|
$10,000
$1.71 P/Share
|
|
Jun 17
2025
|
Philippe Sauvage Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+28.77%
|
$4,000
$1.79 P/Share
|
|
Jun 16
2025
|
David Hung PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
500,000
+0.84%
|
$500,000
$1.79 P/Share
|
|
Jun 16
2025
|
Kerry Wentworth CHIEF REGULATORY OFFICER |
BUY
Open market or private purchase
|
Direct |
50,000
+41.22%
|
$50,000
$1.8 P/Share
|
|
Jun 16
2025
|
Colleen Sjogren Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+38.17%
|
$50,000
$1.81 P/Share
|
|
Jun 16
2025
|
Philippe Sauvage Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,300
+35.86%
|
$3,300
$1.84 P/Share
|
|
May 02
2025
|
Dongfang Liu CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,000
-62.5%
|
$40,000
$2.5 P/Share
|
|
May 02
2025
|
Dongfang Liu CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+38.46%
|
$20,000
$1.94 P/Share
|
|
Apr 07
2025
|
David Hung PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
300,000
+0.51%
|
$300,000
$1.62 P/Share
|
|
Apr 04
2025
|
David Hung PRESIDENT AND CEO |
BUY
Open market or private purchase
|
Direct |
200,000
+0.34%
|
$200,000
$1.66 P/Share
|
|
Apr 01
2025
|
Robert Mashal |
BUY
Open market or private purchase
|
Indirect |
100,000
+17.08%
|
$100,000
$1.67 P/Share
|